Obesity
Conference Coverage
Endoscopic obesity treatments offer alternatives to surgery
These methods have shown lower efficacy but with fewer adverse effects.
From the Journals
Excess weight over lifetime hikes risk for colorectal cancer
Previous studies may have underestimated the risk for CRC because they have looked at excess weight at a single point.
From the Journals
Sleeve, RYGB reduce liver fat in type 2 diabetes
Both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are effective at improving hepatic steatosis in type 2 diabetes patients,...
Private Practice Perspectives
The importance of education and screening for nonalcoholic fatty liver disease
The number of patients we see with NALFD and NASH continues to rise, and it’s taking its toll.
From the Journals
How do alcohol, obesity impact cirrhosis?
A new analysis suggests that, while alcohol and obesity are risk factors for morbidity, they don’t combine for a stronger effect.
From the Journals
Procedureless intragastric balloon may cut costs as well as weight
The novel obesity treatment was found to be a cost-effective step and may prove attractive for patients who wish to avoid surgery altogether.
Feature
Call to Action: Multidisciplinary panel urges coordinated care for ‘NASH epidemic’
News
AGA Clinical Practice Update: Early complications after bariatric/metabolic surgery
The seven advice statements range from a call for high familiarity with interventions to specific approaches for managing postoperative leaks.
Conference Coverage
Semaglutide boosts weight loss following endoscopic gastroplasty
Five patients in the combination group reverted to a nondiabetic state and were able to discontinue antidiabetic medications altogether.
From the Journals
The Mediterranean diet, already beneficial in NAFLD, gets a green boost
Having another dietary option to offer our patients is always a welcome addition to the menu.